May 30, 2026 - 03:59

Assurant, the global insurance and risk management company known by the ticker AIZ, is betting big on technology to fuel its next phase of growth. The firm is deploying a mix of artificial intelligence, automation, and advanced digital platforms to overhaul key operations, from how it handles insurance claims to how it manages the lifecycle of mobile devices and other connected gadgets.
A central focus of this strategy is improving the customer experience. By using AI to analyze data and predict needs, Assurant aims to make interactions faster and more personalized. For example, in its claims processing, automation helps speed up approvals and payouts, reducing the time customers spend waiting. In its device protection business, the company uses digital tools to streamline the entire process of repairing, replacing, or recycling phones and tablets, a market that continues to grow as consumers upgrade their electronics more frequently.
The company also sees technology as a way to cut costs and reduce errors. Automation handles routine tasks that were once done manually, freeing up employees to focus on more complex problems. This shift not only improves efficiency but also helps Assurant scale its services without a proportional increase in overhead. As the company expands into new markets and partnerships, its digital backbone is designed to support that growth without major disruptions. For investors, this tech-driven approach signals a move toward higher margins and more predictable revenue streams, positioning Assurant for steady expansion in a competitive insurance landscape.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...